Home | Free 14-Day Trial | Tutorial | Help
   Print   Email   Bookmark          More
Medical Disability Advisor  >  Cancer Lung  >  Prognosis

Cancer, Lung

Related Terms

  • Bronchogenic Carcinoma
  • Carcinoma of the Lung
  • Lung Cancer
  • Lung Carcinoma
  • Malignant Neoplasm of Bronchus
  • Malignant Neoplasm of the Trachea
  • Non-small Lung Cell Carcinoma
  • NSLCC
  • SCLC
  • Small-cell Lung Carcinoma

Differential Diagnoses

Specialists

  • General Surgeon
  • Oncologist
  • Pulmonologist
  • Radiology Oncologist
  • Thoracic Surgeon

Comorbid Conditions

  • Chronic lung disease (emphysema)
  • Decreased lung function as a result of surgery or radiation therapy

Sign-in as a subscriber or take a free trial to see the renowned Reed Group physiological recovery durations in place of this advertising.

Factors Influencing Duration

Factors that may influence length of disability include the type and stage of the disease at initial presentation, any concurrent infections, overall health, type of treatment, and any complications that may result from treatment. In general, chemotherapy and radiation therapy treatments extend the length of disability.

Length of disability is also dependent on underlying lung function, which can be assessed by periodic pulmonary function tests.

Medical Codes

ICD-9-CM:
162.0 - Malignant Neoplasm of Trachea, Bronchus, and Lung; Trachea; Cartilage of Trachea; Mucosa of Trachea
162.2 - Malignant Neoplasm of Trachea, Bronchus, and Lung; Trachea; Main Bronchus; Carina; Hilus of Lung
162.3 - Neoplasm, Upper Lobe, Bronchus or Lung, Malignant
162.4 - Neoplasm, Middle Lobe, Bronchus or Lung, Malignant
162.5 - Neoplasm, Lower Lobe, Bronchus or Lung, Malignant
162.8 - Neoplasm, Other Parts of Bronchus or Lung, Malignant
162.9 - Malignant Neoplasm of Trachea, Bronchus, and Lung; Bronchus and Lung, Unspecified
197.0 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Lung, Bronchus
231.2 - Carcinoma in Situ of Bronchus and Lung; Carina, Hilus of Lung

Prognosis

The 5-year survival rate is 15% for all stages of lung cancer combined. Individuals who are diagnosed and treated before the cancer has metastasized to the lymph nodes or other organs will have a 5-year survival rate of 49%; however, only 16% of individuals are diagnosed this early ("Detailed Guide").

Source: Medical Disability Advisor






Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to:
Sales Customer Support Content Development
 
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.